Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James T. Parsons currently holds 41,849 shares of DiaMedica Therapeutics Inc. (DMAC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James T. Parsons has been a net seller of DMAC stock. They have purchased $19.3K and sold $134.3K worth of shares.
James T. Parsons's most recent insider trade was on Mar 11, 2026, when they purchased 10,000 shares at $1.03 per share.
James T. Parsons serves as Executive at DiaMedica Therapeutics Inc. (DMAC). They have executed 10 insider transactions totaling $153.6K over their tenure at the company.
James T. Parsons holds the position of Executive at DiaMedica Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
James T. Parsons has shown a selling trading pattern, with $19.3K in total purchases and $134.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James T. Parsons was on Jan 8, 2021, when they sold $134.3K worth of TRIL shares. This transaction involved 8,505 shares at $15.79 per share.
James T. Parsons currently owns 41,849 shares of DiaMedica Therapeutics Inc. (DMAC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James T. Parsons's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James T. Parsons has 10 Form 4 filings on record as an insider at DiaMedica Therapeutics Inc..
Set alerts for James T. Parsons and 40,000+ other insiders.